The involvement of sphingolipids in multidrug resistance

Journal of Membrane Biology

Volumn 181, Issue 3, 2001, Pages 153-162

  Sietsma, H ^a   Veldman, R J ^b   Kok, J W ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b CHU RANGUEIL   (France)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Ceramide; Glucosylceramide Synthase; Multidrug resistance; P glycoprotein; Sphingolipids; Sphingomyelin

Indexed keywords

CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; GLYCOPROTEIN; SPHINGOLIPID; SPHINGOMYELIN;

APOPTOSIS; CANCER CHEMOTHERAPY; CYTOTOXICITY; ENZYME ACTIVITY; GLYCOSYLATION; LIPID COMPOSITION; LIPID METABOLISM; MEMBRANE STRUCTURE; MULTIDRUG RESISTANCE; REVIEW; TUMOR CELL CULTURE;

EID: 0035367339     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-001-0033-1     Document Type: Review

References (96)

1. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth
2. Modulation of carcinoembryonic antigen release by glucosylceramide - Implications for HT29 cell differentiation
3. General principles of chemotherapy
4. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs and toxins and hyperthermia
5. Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833
6. Drug resistance: Genotype versus phenotype - Thirty-second G. H. A. Clowes Memorial Award Lecture
7. P-glycoprotein multidrug resistance and cancer
8. Ceramide synthase mediates daunorubicininduced apoptosis: An alternative mechanism for generating death signals
9. Mechanism of multidrug resistance
10. Tamoxifen retards glycosphingolipid metabolism in human cancer cells
11. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation
12. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface
13. Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses
14. Drug-target interactions: Only the first step in the commitment to a programmed cell death?
15. Ceramide activates heterotrimeric protein phosphatase 2A
16. The effects of lipids and detergents on ATPase-active P-glycoprotein
17. Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport
18. i homeostasis in MRPI overexpressing cells
19. Decreased DNA topoisomerase in daunorubicin-resistant Ehrlich ascites tumor cells
20. Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver
21. Biochemistry of multidrug resistance mediated by the multidrug transporter
22. SDZ PSC833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein
23. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs
24. Mammalian multidrug resistance gene complete cDNA sequence indicates strong homology to bacterial transport proteins
25. Functions of ceramide in coordinating cellular responses to stress
26. Apoptosis and the dilemma of cancer chemotherapy
27. Sphingolipid breakdown products: Anti-proliferative and tumor-suppressor lipids
28. Ceramide in the eukaryotic stress response
29. Is the multidrug transporter a flippase?
30. Structural, mechanistic and clinical aspects of MRPI
31. A mouse B16 melanoma mutant deficient in glycolipids
32. Daunorubicin-induced apoptosis: Triggering of ceramide generation through sphingomyelin hydrolysis
33. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions
34. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: A cautionary note
35. The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance
36. Differential expression of sphingolipids in MRPI overexpressing HT29 cells
37. Regulation of intracellular ceramide content in B16 melanoma cells. Biological implications of ceramide glycosylation
38. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
39. Membrane microdomains and caveolae
40. 6-fold increased cell sensitivity to verocytotoxin. Role of P-glycoprotein in glycolipid synthesis
41. Lactosylceramide is synthesized in the lumen of the Golgi apparatus
42. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance
43. Accumulation of glucosylceramides in multidrug-resistant cancer cells
44. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
45. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells
46. Changes in membrane microdomains and caveolae constituents in multidrug-resistant cancer cells
47. Signaling sphingomyelinases: Which, where, how and why?
48. Multidrug-resistance phenotype in Chinese hamster ovary cells
49. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase
50. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells
51. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis
52. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance
53. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
54. Glucosylceramide: A marker for multiple-drug resistant cancers
55. Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver
56. Signal transduction of stress via ceramide
57. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines
58. Plasma membrane lipid composition of vinblastine sensitive and resistant human leukemic lymphoblasts
59. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells
60. Organization of lipids in the plasma membranes of malignant and stimulated cells: A new model
61. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid
62. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
63. Programmed cell death induced by ceramide
64. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
65. Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice
66. Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents
67. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis
68. The role of ceramide in cell signaling
69. Alteration of plasma membrane glycopeptides and gangliosides of Chinese hamster cells accompanying development of resistance to daunorubicin and vincristine
70. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances
71. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane
72. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells
73. The role of the MDR protein in altered drug translocation across tumor cell membranes
74. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
75. Effects of sphingosine stereoisomers on P-glycoprotein phosphorylation and vinblastine accumulation in multidrug-resistant MCF-7 cells
76. Induction of ceramide glucosyltransferase activity in cultured human keratinocytes. Correlation with culture differentiation
77. Apoptosis. Biochemical events relevance to cancer chemotherapy
78. Stimulation of P-glycoprotein-mediated drug transport by prozasin and progesterone. Evidence for a third drug binding site
79. 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine
80. The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice
81. prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2
82. 1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells
83. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling
84. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II
85. Flow cytometric analysis of glutathione-S-transferase-pi in acute leukemia
86. BCL-X expression in multiple myeloma: Possible indicator of chemoresistance
87. Ganglioside metabolism. Enzymology, topology, and regulation
88. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
89. 6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity
90. rev cells
91. Inhibition of P-glycoprotein activity and chemosensitization of multidrug-resistant ovarian carcinoma 2780AD cells by hexanoylglucosylceramide
92. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy
93. Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway
94. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells
95. Endogenous glycosphingolipids move to the cell surface at a rate consistent with bulk flow estimates
96. Use of photoactivatable sphingolipid analogues to monitor lipid transport in mammalian cells